Proteomics can significantly enhance risk assessment by providing detailed molecular insights into toxicant-induced changes at the protein level. This can lead to the identification of specific protein biomarkers that signal early toxic effects, allowing for more accurate and predictive models of toxicity. By integrating proteomic data with other omics technologies, researchers can develop comprehensive profiles of toxicological responses, leading to improved safety evaluations and regulatory decisions.
